SARMs and CBD: Navigating Regulatory Gaps in UK's Food Industry - Unusual products blur the lines between food and medicine, prompting questions about effective regulation.
David Shurtleff, PhD, Deputy Director at the National Center for Complementary and Integrative Health, National Institutes of Health (NIH), shares his thoughts on closing gaps in cannabinoid research to make progress in pain management.
Farrukh Saleem, Head of Sales & Marketing at Winchester MD, explains why the company is ahead of the curve when it comes to today’s market for CBD products.
Here, OilsBySimpson Founder Kevin Simpson and Clinical Professor, Consultant Physician and Research Director, Filip Krag Knop, explain what we know so far about CBD’s effect on Type 2 diabetes and why running a clinical trial is so important.
Lorenza Romanese, Managing Director of the European Industrial Hemp Association (EIHA) examines the future of hemp and explains in this vein, what is at stake, as well as looking back at its fascinating history.
